Menu
1-702-720-6310 info@microcapspecualtors.com

5 Reasons Big Biotech Could Gain 25%-30% – Barron’s


Barron’s
5 Reasons Big Biotech Could Gain 25%-30%
Barron’s
Leerink analyst Geoffrey Porges sees a light at the end of the tunnel for Big Biotech. In a note published today, he predicted that the stocks in his coverage area could shake off the doldrums, and climb 25% to 30% in the. Illustration: Getty Images

Search